Contact: Christian Basi
University of Missouri-Columbia
Caption: A University of Missouri researcher is beginning to plan for clinical trials with a drug that could block cachexia, a wasting disease, from occurring in cancer patients, giving physicians additional time and treatment options.
Credit: Nathan Hurst/University of Missouri
Usage Restrictions: None
Related news release: MU researcher close to solving problem for cancer patients